| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Comparison of Regorafenib and TAS-102 for Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis
|
Abrahao, Ana B.K.
|
|
2018
|
17 |
2 |
p. 113-120
|
artikel
|
| 2 |
Addressing Racial Disparity in Colorectal Cancer Screening With CT Colonography: Experience in an African-American Cohort
|
Moreno, Courtney C.
|
|
2018
|
17 |
2 |
p. e363-e367
|
artikel
|
| 3 |
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study
|
Oki, Eiji
|
|
2018
|
17 |
2 |
p. 147-155
|
artikel
|
| 4 |
A Phase I Study of Irinotecan, Capecitabine (Xeloda), and Oxaliplatin in Patients With Advanced Colorectal Cancer
|
Maroun, Jean
|
|
2018
|
17 |
2 |
p. e257-e268
|
artikel
|
| 5 |
A Randomized Phase II Study of Axitinib as Maintenance Therapy After First-line Treatment for Metastatic Colorectal Cancer
|
Grávalos, Cristina
|
|
2018
|
17 |
2 |
p. e323-e329
|
artikel
|
| 6 |
Association of CDX2 Expression With Survival in Early Colorectal Cancer: A Systematic Review and Meta-analysis
|
Tomasello, Gianluca
|
|
2018
|
17 |
2 |
p. 97-103
|
artikel
|
| 7 |
Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype–Phenotype Features—An Entity With an Increasing Incidence?
|
Jordan, Emmet J.
|
|
2018
|
17 |
2 |
p. e315-e321
|
artikel
|
| 8 |
Cardiorespiratory Fitness and Body Composition Responses to Different Intensities and Frequencies of Exercise Training in Colorectal Cancer Survivors
|
Devin, James L.
|
|
2018
|
17 |
2 |
p. e269-e279
|
artikel
|
| 9 |
Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review
|
Lacouture, Mario E.
|
|
2018
|
17 |
2 |
p. 85-96
|
artikel
|
| 10 |
Editorial Board
|
|
|
2018
|
17 |
2 |
p. A1
|
artikel
|
| 11 |
Effectiveness of Cetuximab as First-Line Therapy for Patients With Wild-Type KRAS and Unresectable Metastatic Colorectal Cancer in Real-Life Practice: Results of the EREBUS Cohort
|
Rouyer, Magali
|
|
2018
|
17 |
2 |
p. 129-139
|
artikel
|
| 12 |
Efficacy of Mobile Health Care Application and Wearable Device in Improvement of Physical Performance in Colorectal Cancer Patients Undergoing Chemotherapy
|
Cheong, In Yae
|
|
2018
|
17 |
2 |
p. e353-e362
|
artikel
|
| 13 |
Evidence Suggests Sphingosine 1-Phosphate Might Be Actively Generated, Degraded, and Transported to Extracellular Spaces With Increased S1P2 and S1P3 Expression in Colon Cancer
|
Uranbileg, Baasanjav
|
|
2018
|
17 |
2 |
p. e171-e182
|
artikel
|
| 14 |
Frequency of Surveillance and Impact of Surveillance Colonoscopies in Patients With Ulcerative Colitis Who Developed Colorectal Cancer
|
Cole, Elisabeth B.
|
|
2018
|
17 |
2 |
p. e289-e292
|
artikel
|
| 15 |
Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand–Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib
|
Suenaga, Mitsukuni
|
|
2018
|
17 |
2 |
p. e395-e414
|
artikel
|
| 16 |
Hormone Replacement Therapy and Colorectal Cancer Incidence and Mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
|
Symer, Matthew M.
|
|
2018
|
17 |
2 |
p. e281-e288
|
artikel
|
| 17 |
Incidence, Management, and Implications of Visceral Thrombosis in Pancreatic Ductal Adenocarcinoma
|
Mier-Hicks, Angel
|
|
2018
|
17 |
2 |
p. 121-128
|
artikel
|
| 18 |
Individual Susceptibility Analysis Using Patient-derived Slice Cultures of Colorectal Carcinoma
|
Sönnichsen, Rasmus
|
|
2018
|
17 |
2 |
p. e189-e199
|
artikel
|
| 19 |
Integrating Downstaging in the Risk Assessment of Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: Validation of Valentini's Nomograms and the Neoadjuvant Rectal Score
|
Roselló, Susana
|
|
2018
|
17 |
2 |
p. 104-112.e2
|
artikel
|
| 20 |
Leptomeningeal Carcinomatosis in Colorectal Cancer: The Mayo Clinic Experience
|
Taylor, Gretchen
|
|
2018
|
17 |
2 |
p. e183-e187
|
artikel
|
| 21 |
LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer—Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result
|
Rodia, Maria Teresa
|
|
2018
|
17 |
2 |
p. e217-e228
|
artikel
|
| 22 |
Mutation and Methylation Analysis of Circulating Tumor DNA Can Be Used for Follow-up of Metastatic Colorectal Cancer Patients
|
Boeckx, Nele
|
|
2018
|
17 |
2 |
p. e369-e379
|
artikel
|
| 23 |
Nucleotide Excision Repair Capacity and XPC and XPD Gene Polymorphism Modulate Colorectal Cancer Risk
|
Mucha, Bartosz
|
|
2018
|
17 |
2 |
p. e435-e441
|
artikel
|
| 24 |
Optimal Interval for 18F-FDG-PET After Chemoradiotherapy for Rectal Cancer
|
Kawai, Kazushige
|
|
2018
|
17 |
2 |
p. e163-e170
|
artikel
|
| 25 |
Pattern and Management of Recurrence of Mid-Low Rectal Cancer After Neoadjuvant Intensity-Modulated Radiotherapy: Single-Center Results of 687 Cases
|
Wu, Ai-Wen
|
|
2018
|
17 |
2 |
p. e307-e313
|
artikel
|
| 26 |
Phase I Trial of Anti-MET Monoclonal Antibody in MET-Overexpressed Refractory Cancer
|
Lee, Jeeyun
|
|
2018
|
17 |
2 |
p. 140-146
|
artikel
|
| 27 |
Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer
|
Wiesweg, Marcel
|
|
2018
|
17 |
2 |
p. e331-e352
|
artikel
|
| 28 |
Planned Safety Analysis of the ACTS-CC 02 Trial: A Randomized Phase III Trial of S-1 With Oxaliplatin Versus Tegafur and Uracil With Leucovorin as Adjuvant Chemotherapy for High-Risk Stage III Colon Cancer
|
Kusumoto, Tetsuya
|
|
2018
|
17 |
2 |
p. e153-e161
|
artikel
|
| 29 |
Primary Tumor Location and Survival in the General Population With Metastatic Colorectal Cancer
|
Ahmed, Shahid
|
|
2018
|
17 |
2 |
p. e201-e206
|
artikel
|
| 30 |
Regorafenib or Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer? A Perspective on the Basis of Pharmacological Costs
|
Giuliani, Jacopo
|
|
2018
|
17 |
2 |
p. e381-e383
|
artikel
|
| 31 |
Review of Blood-Based Colorectal Cancer Screening: How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation?
|
Worm Ørntoft, Mai-Britt
|
|
2018
|
17 |
2 |
p. e415-e433
|
artikel
|
| 32 |
Significance of PITX2 Promoter Methylation in Colorectal Carcinoma Prognosis
|
Semaan, Alexander
|
|
2018
|
17 |
2 |
p. e385-e393
|
artikel
|
| 33 |
Survival Benefit of Palliative Local Treatments and Efficacy of Different Pharmacotherapies in Colorectal Cancer With Lung Metastasis: Results From a Large Retrospective Study
|
Wang, Zhenghang
|
|
2018
|
17 |
2 |
p. e233-e255
|
artikel
|
| 34 |
Survival Impact of CAPOX Versus FOLFOX in the Adjuvant Treatment of Stage III Colon Cancer
|
Loree, Jonathan M.
|
|
2018
|
17 |
2 |
p. 156-163
|
artikel
|
| 35 |
Table of Contents
|
|
|
2018
|
17 |
2 |
p. A3-A9
|
artikel
|
| 36 |
Two Months of Therapy: A Case of Pathologic Complete Response to Chemoimmunotherapy in a Patient With Metastatic Colorectal Cancer
|
Armstrong, Samantha
|
|
2018
|
17 |
2 |
p. e229-e232
|
artikel
|
| 37 |
Update on Hereditary Colorectal Cancer: Improving the Clinical Utility of Multigene Panel Testing
|
Lorans, Marie
|
|
2018
|
17 |
2 |
p. e293-e305
|
artikel
|
| 38 |
Visceral Thromboses in Pancreas Adenocarcinoma: Systematic Review
|
Hicks, Angel Mier
|
|
2018
|
17 |
2 |
p. e207-e216
|
artikel
|
Tijdschrift beschrijving